AI Buyer Insights:

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Torl Biotherapeutics Tech Stack and Enterprise Applications

Torl Biotherapeutics HCM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Rippling Legacy Rippling ATS Applicant Tracking System HCM n/a 2025 2025
Torl Biotherapeutics Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Google Legacy Google Workspace (Formerly Google G-Suite) Collaboration Collaboration n/a 2023 2023
Collaboration Collaboration 2024 2024
Collaboration Collaboration 2025 2025
Torl Biotherapeutics Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Automattic Legacy WordPress Web Content Management Content Management n/a 2025 2025
Torl Biotherapeutics CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Tag Management CRM 2025 2025
Torl Biotherapeutics PPM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Project Portfolio Management PPM 2025 2025
Torl Biotherapeutics IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2024 2024
Content Delivery Network IaaS 2025 2025
Content Delivery Network IaaS 2025 2025
Content Delivery Network IaaS 2025 2025
Domain Name System (DNS) IaaS 2023 2023
Domain Name System (DNS) IaaS 2023 2023
Domain Name System (DNS) IaaS 2025 2025

IT Decision Makers and Key Stakeholders at Torl Biotherapeutics

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by Torl Biotherapeutics Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Torl Biotherapeutics IT executives and key decision makers. This section highlights Torl Biotherapeutics's latest recorded technology evaluations, including Intuit Quickbooks Enterprise for ERP Financial on 2026-01-29. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Torl Biotherapeutics digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
2026-01-29 Torl Biotherapeutics Evaluated Intuit Intuit Quickbooks Enterprise ERP Financial ERP
FAQ - APPS RUN THE WORLD Torl Biotherapeutics Technographics
Torl Biotherapeutics is a Life Sciences organization based in United States, with around 50 employees and annual revenues of $10.0 million.
Torl Biotherapeutics operates a diverse technology stack with applications such as Rippling ATS, Google Workspace (Formerly Google G-Suite) and WordPress, covering areas like Applicant Tracking System, Collaboration and Web Content Management.
Torl Biotherapeutics has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Rippling, Google and Automattic.
Torl Biotherapeutics recently adopted applications including Rippling ATS in 2025, GoDaddy Webmail in 2025 and WordPress in 2025, highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Torl Biotherapeutics’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates Torl Biotherapeutics’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Torl Biotherapeutics technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.